Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1968 1
1969 2
1970 2
1971 1
1972 3
1973 8
1974 1
1975 1
1976 3
1977 5
1978 6
1979 12
1980 18
1981 11
1982 12
1983 20
1984 27
1985 31
1986 40
1987 31
1988 31
1989 35
1990 30
1991 45
1992 38
1993 50
1994 49
1995 46
1996 47
1997 43
1998 20
1999 31
2000 28
2001 20
2002 29
2003 21
2004 17
2005 24
2006 18
2007 23
2008 20
2009 22
2010 35
2011 26
2012 26
2013 24
2014 21
2015 28
2016 18
2017 22
2018 21
2019 13
2020 25
2021 26
2022 16
2023 22
2024 19
2025 21
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,218 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials.
Abdelmonem H, Abdelhay HM, Abdelwadoud GT, Alhosini ANM, Ahmed AE, Mohamed SW, Al-Dardery NM, Abd-ElGawad M, Kamel MA. Abdelmonem H, et al. BMC Neurol. 2023 Jun 8;23(1):221. doi: 10.1186/s12883-023-03259-7. BMC Neurol. 2023. PMID: 37291500 Free PMC article.
In the recurrence rate, studies showed no significant difference between metoclopramide and other drugs. Metoclopramide significantly decreased nausea more than the placebo. ...The reported extrapyramidal symptoms with metoclopramide were dystonia or akathisi …
In the recurrence rate, studies showed no significant difference between metoclopramide and other drugs. Metoclopramide signif …
Is metoclopramide beneficial for the postpyloric placement of nasoenteric tubes? A systematic review and meta-analysis of randomized controlled trials.
Ouyang X, Qu R, Hu B, Wang Y, Yao F, Lv B, Sun C, Deng Y, Chen C. Ouyang X, et al. Nutr Clin Pract. 2022 Apr;37(2):316-327. doi: 10.1002/ncp.10725. Epub 2021 Jun 22. Nutr Clin Pract. 2022. PMID: 34155678 Free PMC article.
BACKGROUND: Metoclopramide is frequently prescribed as an adjuvant for the postpyloric placement of nasoenteric tubes (NETs). However, a recent meta-analysis showed that metoclopramide was not beneficial in adults. Thus, this study aimed to reevaluate the effect of …
BACKGROUND: Metoclopramide is frequently prescribed as an adjuvant for the postpyloric placement of nasoenteric tubes (NETs). However …
Metoclopramide for preventing nosocomial pneumonia in patients fed via nasogastric tubes: a systematic review and meta-analysis of randomized controlled trials.
Liu Y, Dong X, Yang S, Wang A, Wang M. Liu Y, et al. Asia Pac J Clin Nutr. 2017;26(5):820-828. doi: 10.6133/apjcn.102016.01. Asia Pac J Clin Nutr. 2017. PMID: 28802291 Free article.
BACKGROUND AND OBJECTIVES: Metoclopramide, a prokinetic agent, has been recommended to reduce incidence of pneumonia, but its efficacy is controversial. ...However, in two other trials using dichotomous data, metoclopramide increased the proportion of cases showing …
BACKGROUND AND OBJECTIVES: Metoclopramide, a prokinetic agent, has been recommended to reduce incidence of pneumonia, but its efficac …
Use of metoclopramide in the first trimester and risk of major congenital malformations: A systematic review and meta-analysis.
Sun L, Xi Y, Wen X, Zou W. Sun L, et al. PLoS One. 2021 Sep 20;16(9):e0257584. doi: 10.1371/journal.pone.0257584. eCollection 2021. PLoS One. 2021. PMID: 34543335 Free PMC article.
RESULTS: Six studies assessing a total number of 33374 metoclopramide-exposed and 373498 controls infants were included in this meta-analysis. No significant increase in the rate of major congenital malformation was detected following metoclopramide use during first …
RESULTS: Six studies assessing a total number of 33374 metoclopramide-exposed and 373498 controls infants were included in this meta- …
Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials.
Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH. Colman I, et al. BMJ. 2004 Dec 11;329(7479):1369-73. doi: 10.1136/bmj.38281.595718.7C. Epub 2004 Nov 18. BMJ. 2004. PMID: 15550401 Free PMC article.
In studies comparing metoclopramide with placebo, metoclopramide was more likely to provide significant reduction in migraine pain (odds ratio 2.84, 95% confidence interval 1.05 to 7.68). ...CONCLUSIONS: Metoclopramide is an effective treatment for migraine h …
In studies comparing metoclopramide with placebo, metoclopramide was more likely to provide significant reduction in migraine …
Metoclopramide for post-pyloric placement of naso-enteral feeding tubes.
Silva CC, Bennett C, Saconato H, Atallah ÁN. Silva CC, et al. Cochrane Database Syst Rev. 2015 Jan 7;1(1):CD003353. doi: 10.1002/14651858.CD003353.pub2. Cochrane Database Syst Rev. 2015. PMID: 25564770 Free PMC article.
Moreover, metoclopramide may include adverse reactions, which with high doses or prolonged use may be serious and irreversible. ...MAIN RESULTS: Four studies, with a total of 204 participants were included and analysed. The trials compared metoclopramide with placeb …
Moreover, metoclopramide may include adverse reactions, which with high doses or prolonged use may be serious and irreversible. ...MA …
Intravenous ketorolac versus metoclopramide in adult patients with migraine headaches: An updated systematic review and meta-analysis.
Song Q, Yang H, Yang X. Song Q, et al. Adv Clin Exp Med. 2024 Jul;33(7):661-667. doi: 10.17219/acem/171697. Adv Clin Exp Med. 2024. PMID: 37849443 Free article.
BACKGROUND: Intravenous ketorolac and metoclopramide are common emergency treatments for adult patients with migraine headaches. The comparison between ketorolac and metoclopramide for migraine treatment is an intriguing issue for research and clinical practice. ...
BACKGROUND: Intravenous ketorolac and metoclopramide are common emergency treatments for adult patients with migraine headaches. The …
Efficacy of acupoint injection of metoclopramide for post-chemotherapy vomiting: A systematic review and meta-analysis.
Ai M, Cai Y, Zeng Y, Xiong D. Ai M, et al. Medicine (Baltimore). 2024 Apr 5;103(14):e37569. doi: 10.1097/MD.0000000000037569. Medicine (Baltimore). 2024. PMID: 38579100 Free PMC article.
The purpose of this study was to systematically review the clinical efficacy of acupoint injection of metoclopramide in the treatment of post-chemotherapy vomiting. METHODS: We searched 4 general English databases and 4 conventional Chinese databases, all with a time frame …
The purpose of this study was to systematically review the clinical efficacy of acupoint injection of metoclopramide in the treatment …
Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies.
Henzi I, Walder B, Tramèr MR. Henzi I, et al. Br J Anaesth. 1999 Nov;83(5):761-71. doi: 10.1093/bja/83.5.761. Br J Anaesth. 1999. PMID: 10690140 Free article.
Metoclopramide has been used for almost 40 yr to prevent postoperative nausea and vomiting (PONV). ...Minor drug-related adverse effects (sedation, dizziness, drowsiness) were not significantly associated with metoclopramide. There was one adult who experienced extr …
Metoclopramide has been used for almost 40 yr to prevent postoperative nausea and vomiting (PONV). ...Minor drug-related adverse effe …
Systemic metoclopramide to prevent postoperative nausea and vomiting: a meta-analysis without Fujii's studies.
De Oliveira GS Jr, Castro-Alves LJ, Chang R, Yaghmour E, McCarthy RJ. De Oliveira GS Jr, et al. Br J Anaesth. 2012 Nov;109(5):688-97. doi: 10.1093/bja/aes325. Epub 2012 Sep 25. Br J Anaesth. 2012. PMID: 23015617 Free article.
Thirty trials evaluating the effect of 10 mg systemic metoclopramide in 3328 subjects on PONV outcomes were included. Metoclopramide reduced the incidence of 24 h PONV compared with control, odds ratio (OR) [95% confidence interval (CI)] of 0.58 (0.43-0.78), number …
Thirty trials evaluating the effect of 10 mg systemic metoclopramide in 3328 subjects on PONV outcomes were included. Metocloprami …
1,218 results